Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 7, 2016; 22(9): 2779-2788
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2779
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2779
Figure 6 Gadd45a inhibits the transforming growth factor-β/Smad signaling pathways partly due to its antioxidant properties.
A: Relative mRNA expression of type I collagen and α-SMA as determined by quantitative RT-PCR. Hepatic stellate cells were stimulated with CCl4 in the presence or absence of glutathione for 24 h; B: Western blot analyses of type I collagen and α-SMA expression; C: Activation of the TGF-β/Smad signaling pathways was measured by Western blot analyses of p-Smad2, p-Smad3, Smd2, Smad3, and Smad4. GSH: Glutathione; SMA: Smooth muscle actin; TGF: Transforming growth factor.
- Citation: Hong L, Sun QF, Xu TY, Wu YH, Zhang H, Fu RQ, Cai FJ, Zhou QQ, Zhou K, Du QW, Zhang D, Xu S, Ding JG. New role and molecular mechanism of Gadd45a in hepatic fibrosis. World J Gastroenterol 2016; 22(9): 2779-2788
- URL: https://www.wjgnet.com/1007-9327/full/v22/i9/2779.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i9.2779